申请人:SmithKline Beecham Corporation
公开号:US06297265B2
公开(公告)日:2001-10-02
This invention relates to novel benzoisothiazole substituted compounds, pharmaceutical compositions, processes for their preparation, and use thereof in treating IL-8, GRO&agr;, GRO&bgr;, GRO&ggr;, ENA-78 and NAP-2 mediated diseases.
本发明涉及新型苯并异噻唑取代化合物、制备它们的制剂、制备过程以及在治疗IL-8、GROα、GROβ、GROγ、ENA-78和NAP-2介导的疾病中使用它们的用途。